From gestalt to gene: early predictive dysmorphic features of PMM2-CDG. Issue 4 (21st November 2018)
- Record Type:
- Journal Article
- Title:
- From gestalt to gene: early predictive dysmorphic features of PMM2-CDG. Issue 4 (21st November 2018)
- Main Title:
- From gestalt to gene: early predictive dysmorphic features of PMM2-CDG
- Authors:
- Martinez-Monseny, Antonio
Cuadras, Daniel
Bolasell, Mercè
Muchart, Jordi
Arjona, César
Borregan, Mar
Algrabli, Adi
Montero, Raquel
Artuch, Rafael
Velázquez-Fragua, Ramón
Macaya, Alfons
Pérez-Cerdá, Celia
Pérez-Dueñas, Belén
Pérez, Belén
Serrano, Mercedes - Other Names:
- author non-byline.
Aguilera-Albesa Sergio author non-byline.
Gutierrez-Solana Luis G author non-byline.
López Laura author non-byline.
Felipe Ana author non-byline.
Miranda Mª Concepción author non-byline.
Carratala Francisco author non-byline.
Yoldi M Eugenia author non-byline.
López-laso Eduardo author non-byline.
Sierra-córcoles Mª Concepción author non-byline.
Sebastián-garcía Irma author non-byline.
Aísa Eduardo author non-byline.
Cancho-Candela Ramon author non-byline.
Carrasco-Marina M Llanos author non-byline.
Couce María L author non-byline.
Roldán Susana author non-byline.
Morales Montserrat author non-byline.
Conde-Lorenzo Noemi author non-byline.
Garcia Oscar author non-byline. - Abstract:
- Abstract : Introduction: Phosphomannomutase-2 deficiency (PMM2-CDG) is associated with a recognisable facial pattern. There are no early severity predictors for this disorder and no phenotype–genotype correlation. We performed a detailed dysmorphology evaluation to describe facial gestalt and its changes over time, to train digital recognition facial analysis tools and to identify early severity predictors. Methods: Paediatric PMM2-CDG patients were evaluated and compared with controls. A computer-assisted recognition tool was trained. Through the evaluation of dysmorphic features (DFs), a simple categorisation was created and correlated with clinical and neurological scores, and neuroimaging. Results: Dysmorphology analysis of 31 patients (4–19 years of age) identified eight major DFs (strabismus, upslanted eyes, long fingers, lipodystrophy, wide mouth, inverted nipples, long philtrum and joint laxity) with predictive value using receiver operating characteristic (ROC) curveanalysis (p<0.001). Dysmorphology categorisation using lipodystrophy and inverted nipples was employed to divide patients into three groups that are correlated with global clinical and neurological scores, and neuroimaging (p=0.005, 0.003 and 0.002, respectively). After Face2Gene training, PMM2-CDG patients were correctly identified at different ages. Conclusions: PMM2-CDG patients' DFs are consistent and inform about clinical severity when no clear phenotype–genotype correlation is known. We propose aAbstract : Introduction: Phosphomannomutase-2 deficiency (PMM2-CDG) is associated with a recognisable facial pattern. There are no early severity predictors for this disorder and no phenotype–genotype correlation. We performed a detailed dysmorphology evaluation to describe facial gestalt and its changes over time, to train digital recognition facial analysis tools and to identify early severity predictors. Methods: Paediatric PMM2-CDG patients were evaluated and compared with controls. A computer-assisted recognition tool was trained. Through the evaluation of dysmorphic features (DFs), a simple categorisation was created and correlated with clinical and neurological scores, and neuroimaging. Results: Dysmorphology analysis of 31 patients (4–19 years of age) identified eight major DFs (strabismus, upslanted eyes, long fingers, lipodystrophy, wide mouth, inverted nipples, long philtrum and joint laxity) with predictive value using receiver operating characteristic (ROC) curveanalysis (p<0.001). Dysmorphology categorisation using lipodystrophy and inverted nipples was employed to divide patients into three groups that are correlated with global clinical and neurological scores, and neuroimaging (p=0.005, 0.003 and 0.002, respectively). After Face2Gene training, PMM2-CDG patients were correctly identified at different ages. Conclusions: PMM2-CDG patients' DFs are consistent and inform about clinical severity when no clear phenotype–genotype correlation is known. We propose a classification of DFs into major and minor with diagnostic risk implications. At present, Face2Gene is useful to suggest PMM2-CDG. Regarding the prognostic value of DFs, we elaborated a simple severity dysmorphology categorisation with predictive value, and we identified five major DFs associated with clinical severity. Both dysmorphology and digital analysis may help physicians to diagnose PMM2-CDG sooner. … (more)
- Is Part Of:
- Journal of medical genetics. Volume 56:Issue 4(2019)
- Journal:
- Journal of medical genetics
- Issue:
- Volume 56:Issue 4(2019)
- Issue Display:
- Volume 56, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 56
- Issue:
- 4
- Issue Sort Value:
- 2019-0056-0004-0000
- Page Start:
- 236
- Page End:
- 245
- Publication Date:
- 2018-11-21
- Subjects:
- automated facial analysis software -- cerebellar disorders -- congenital disorders of glycosylation -- dysmorphology -- phosphomannomutase
Medical genetics -- Periodicals
616.042 - Journal URLs:
- http://jmg.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/jmedgenet-2018-105588 ↗
- Languages:
- English
- ISSNs:
- 1468-6244
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19741.xml